Gene Therapy Slows Advanced Heart Disease

Gene therapies will some day fix what ails us. That day is getting closer as a gene therapy that introduces a calcium pump enzyme reduces the worsening of advanced heart disease. Researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai reported the long-term benefits of a single dose of their gene therapy AAV1/SERCA2a in advanced heart failure patients on Nov. 19 at the American Heart Association Scientific Sessions 2013. The new long-term follow-up results from their initial Calcium Up-Regulation by Percutaneous Administration of Gene Therapy In Cardiac Disease (CUPID 1) clinical trial found a one-time, high-dose injection of the AAV1/SERCA2a gene therapy results in the presence of the delivered SERCA2a gene up to 31 months...
Source: FuturePundit - Category: Health Medicine and Bioethics Commentators Authors: Source Type: blogs